Advertisement

Index by author

February 01, 1996; Volume 276,Issue 2

  1. Calzadilla, S V

    1. Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.
      T J Opgenorth, A L Adler, S V Calzadilla, W J Chiou, B D Dayton, D B Dixon, L J Gehrke, L Hernandez, S R Magnuson, K C Marsh, E I Novosad, T W Von Geldern, J L Wessale, M Winn and J R Wu-Wong
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 473-481;

  2. Campbell, I G

    1. Noncompetitive NMDA channel blockade during waking intensely stimulates NREM delta.
      I G Campbell and I Feinberg
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 737-742;

  3. Capasso, A

    1. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
      A Capasso, A Di Giannuario, A Loizzo, S Pieretti, S Sagratella and L Sorrentino
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 743-751;

  4. Catlow, J

    1. Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.
      B J Ring, J Catlow, T J Lindsay, T Gillespie, L K Roskos, B J Cerimele, S P Swanson, M A Hamman and S A Wrighton
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 658-666;

  5. Cella, S G

    1. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
      V De Gennaro Colonna, M Zoli, B P Settembrini, S Ciceri, A De Marco, S G Cella, L F Agnati and E E Muller
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 795-800;

  6. Cerimele, B J

    1. Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.
      B J Ring, J Catlow, T J Lindsay, T Gillespie, L K Roskos, B J Cerimele, S P Swanson, M A Hamman and S A Wrighton
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 658-666;

  7. Chan, C K

    1. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
      C K Chan, F Sannajust and G A Head
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 411-420;

  8. Chen, F Y

    1. Inhibition of cerebral neurogenic vasodilation by L-glutamine and nitric oxide synthase inhibitors and its reversal by L-citrulline.
      T J Lee, S Sarwinski, T Ishine, C C Lai and F Y Chen
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 353-358;

  9. Cheramy, A

    1. Cooperative contributions of cholinergic and NMDA receptors in the presynaptic control of dopamine release from synaptosomes of the rat striatum.
      A Chéramy, G Godeheu, M L'Hirondel and J Glowinski
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 616-625;

  10. Chiba, S

    1. Selective inhibition by a class III antiarrhythmic agent, E-4031, of the negative chronotropic response to parasympathetic stimulation in anesthetized dogs.
      H Imamura, Y Furukawa, H Nakano, M Kasama, Y Hoyano and S Chiba
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 467-472;
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue

Advertisement